1	the	the	DT	DT	-	2	NMOD	-	-
2	quality	quality	NN	NN	-	8	SUB	-	-
3	of	of	IN	IN	-	2	NMOD	-	-
4	the	the	DT	DT	-	7	NMOD	-	-
5	full	full	JJ	JJ	-	7	NMOD	-	-
6	product	product	NN	NN	-	7	NMOD	-	-
7	range	range	NN	NN	-	3	PMOD	-	-
8	is	is	VBZ	VBZ	-	0	ROOT	-	-
9	assured	assured	VBN	VBN	-	8	VC	-	-
10	because	because	IN	IN	-	9	VMOD	-	-
11	fluka	fluka	NN	NN	-	21	NMOD	-	-
12	assay	assay	RB	RB	-	21	NMOD	-	-
13	every	every	DT	DT	-	14	NMOD	-	-
14	chemical	chemical	NN	NN	-	21	NMOD	-	-
15	and	and	CC	CC	-	14	AMOD	-	-
16	bio-chemical	bio-chemical	JJ	JJ	-	14	DEP	-	-
17	,	,	,	,	-	21	P	-	-
18	and	and	CC	CC	-	21	NMOD	-	-
19	subject	subject	JJ	JJ	-	21	NMOD	-	-
20	all	all	DT	DT	-	21	NMOD	-	-
21	products	products	NNS	NNS	-	10	PMOD	-	-
22	to	to	TO	TO	-	21	NMOD	-	-
23	exacting	exacting	VBG	VBG	-	22	PMOD	-	-
24	tests	tests	NNS	NNS	-	23	OBJ	-	-
25	in	in	IN	IN	-	23	VMOD	-	-
26	their	their	PRP$	PRP$	-	31	NMOD	-	-
27	well	well	RB	RB	-	28	AMOD	-	-
28	equipped	equipped	VBN	VBN	-	31	NMOD	-	-
29	quality	quality	NN	NN	-	31	NMOD	-	-
30	control	control	NN	NN	-	31	NMOD	-	-
31	laboratories	laboratories	NNS	NNS	-	25	PMOD	-	-
32	.	.	.	.	-	8	P	-	-

1	we	we	PRP	PRP	-	3	SUB	-	-
2	transiently	transiently	RB	RB	-	3	VMOD	-	-
3	expressed	expressed	VBD	VBD	-	0	ROOT	-	-
4	several	several	JJ	JJ	-	5	NMOD	-	-
5	cdnas	cdnas	NNS	NNS	-	3	OBJ	-	-
6	in	in	IN	IN	-	3	VMOD	-	-
7	mammalian	mammalian	JJ	JJ	-	8	NMOD	-	-
8	cells	cells	NNS	NNS	-	6	PMOD	-	-
9	,	,	,	,	-	3	P	-	-
10	then	then	RB	RB	-	3	VMOD	-	-
11	assayed	assayed	VBD	VBD	-	3	VMOD	-	-
12	both	both	DT	DT	-	17	NMOD	-	-
13	cell	cell	NN	NN	-	14	NMOD	-	-
14	lysates	lysates	NNS	NNS	-	17	NMOD	-	-
15	and	and	CC	CC	-	17	NMOD	-	-
16	conditioned	conditioned	VBN	VBN	-	17	NMOD	-	-
17	medium	medium	NN	NN	-	11	OBJ	-	-
18	in	in	IN	IN	-	17	NMOD	-	-
19	a	a	DT	DT	-	23	NMOD	-	-
20	schwann	schwann	NN	NN	-	23	NMOD	-	-
21	cell	cell	NN	NN	-	23	NMOD	-	-
22	proliferation	proliferation	NN	NN	-	23	NMOD	-	-
23	assay	assay	NN	NN	-	18	PMOD	-	-
24	.	.	.	.	-	3	P	-	-

1	rat	rat	NN	NN	-	5	NMOD	-	-
2	sciatic	sciatic	JJ	JJ	-	5	NMOD	-	-
3	nerve	nerve	NN	NN	-	5	NMOD	-	-
4	schwann	schwann	NN	NN	-	5	NMOD	-	-
5	cells	cells	NNS	NNS	-	6	SUB	-	-
6	were	were	VBD	VBD	-	0	ROOT	-	-
7	assayed	assayed	JJ	JJ	-	6	PRD	-	-
8	for	for	IN	IN	-	7	AMOD	-	-
9	incorporation	incorporation	NN	NN	-	8	PMOD	-	-
10	of	of	IN	IN	-	9	NMOD	-	-
11	dna	dna	NN	NN	-	13	NMOD	-	-
12	synthesis	synthesis	NN	NN	-	13	NMOD	-	-
13	precursors	precursors	NNS	NNS	-	10	PMOD	-	-
14	,	,	,	,	-	6	P	-	-
15	as	as	IN	IN	-	6	VMOD	-	-
16	described	described	VBN	VBN	-	15	SBAR	-	-
17	.	.	.	.	-	6	P	-	-

1	tyrosine	tyrosine	NN	NN	-	2	NMOD	-	-
2	phosphorylation	phosphorylation	NN	NN	-	3	SUB	-	-
3	was	was	VBD	VBD	-	0	ROOT	-	-
4	assayed	assayed	VBN	VBN	-	3	VC	-	-
5	by	by	IN	IN	-	4	VMOD	-	-
6	western	western	JJ	JJ	-	5	PMOD	-	-
7	blotting	blotting	VBG	VBG	-	4	VMOD	-	-
8	as	as	IN	IN	-	7	VMOD	-	-
9	described	described	VBN	VBN	-	8	SBAR	-	-
10	,	,	,	,	-	7	P	-	-
11	using	using	VBG	VBG	-	7	VMOD	-	-
12	precast	precast	JJ	JJ	-	16	NMOD	-	-
13	4-12	4-12	CD	CD	-	14	AMOD	-	-
14	%	%	NN	NN	-	16	NMOD	-	-
15	gradient	gradient	NN	NN	-	16	NMOD	-	-
16	gels	gels	NNS	NNS	-	11	OBJ	-	-
17	(	(	-LRB-	-LRB-	-	21	P	-	-
18	novex	novex	NN	NN	-	21	NMOD	-	-
19	,	,	,	,	-	21	P	-	-
20	san	san	JJ	JJ	-	21	NMOD	-	-
21	diego	diego	NN	NN	-	11	OBJ	-	-
22	)	)	-RRB-	-RRB-	-	21	P	-	-
23	.	.	.	.	-	3	P	-	-

1	the	the	DT	DT	-	3	NMOD	-	-
2	purified	purified	JJ	JJ	-	3	NMOD	-	-
3	protein	protein	NN	NN	-	4	SUB	-	-
4	was	was	VBD	VBD	-	0	ROOT	-	-
5	assayed	assayed	VBN	VBN	-	4	VC	-	-
6	at	at	IN	IN	-	5	VMOD	-	-
7	the	the	DT	DT	-	9	NMOD	-	-
8	indicated	indicated	JJ	JJ	-	9	NMOD	-	-
9	concentrations	concentrations	NNS	NNS	-	6	PMOD	-	-
10	for	for	IN	IN	-	9	NMOD	-	-
11	its	its	PRP$	PRP$	-	12	NMOD	-	-
12	ability	ability	NN	NN	-	10	PMOD	-	-
13	to	to	TO	TO	-	14	VMOD	-	-
14	hydrolyse	hydrolyse	VB	VB	-	12	NMOD	-	-
15	p-	p-	JJ	JJ	-	17	NMOD	-	-
16	nitrophenol	nitrophenol	JJ	JJ	-	17	NMOD	-	-
17	phosphate	phosphate	NN	NN	-	14	OBJ	-	-
18	(	(	-LRB-	-LRB-	-	19	P	-	-
19	pnpp	pnpp	NN	NN	-	28	NMOD	-	-
20	)	)	-RRB-	-RRB-	-	19	P	-	-
21	either	either	CC	CC	-	28	NMOD	-	-
22	in	in	IN	IN	-	21	PMOD	-	-
23	the	the	DT	DT	-	24	NMOD	-	-
24	absence	absence	NN	NN	-	22	PMOD	-	-
25	(	(	-LRB-	-LRB-	-	22	P	-	-
26	)	)	-RRB-	-RRB-	-	22	P	-	-
27	or	or	CC	CC	-	28	NMOD	-	-
28	presence	presence	NN	NN	-	14	OBJ	-	-
29	(	(	-LRB-	-LRB-	-	31	P	-	-
30	)	)	-RRB-	-RRB-	-	29	P	-	-
31	of	of	IN	IN	-	28	NMOD	-	-
32	<num>	<num>	CD	CD	-	34	NMOD	-	-
33	sodium	sodium	NN	NN	-	34	NMOD	-	-
34	vanadate	vanadate	NN	NN	-	31	PMOD	-	-
35	.	.	.	.	-	4	P	-	-

1	all	all	DT	DT	-	2	NMOD	-	-
2	samples	samples	NNS	NNS	-	3	SUB	-	-
3	were	were	VBD	VBD	-	22	VMOD	-	-
4	assayed	assayed	VBN	VBN	-	3	VC	-	-
5	in	in	IN	IN	-	4	VMOD	-	-
6	triplicate	triplicate	NN	NN	-	10	NMOD	-	-
7	and	and	CC	CC	-	10	NMOD	-	-
8	the	the	DT	DT	-	10	NMOD	-	-
9	mean	mean	JJ	JJ	-	10	NMOD	-	-
10	value	value	NN	NN	-	5	PMOD	-	-
11	used	used	VBN	VBN	-	10	NMOD	-	-
12	;	;	:	:	-	22	P	-	-
13	lines	lines	NNS	NNS	-	14	SUB	-	-
14	represent	represent	VBP	VBP	-	22	VMOD	-	-
15	standard	standard	JJ	JJ	-	19	NMOD	-	-
16	errors.	errors.	JJ	JJ	-	19	NMOD	-	-
17	b	b	NN	NN	-	19	NMOD	-	-
18	and	and	CC	CC	-	19	NMOD	-	-
19	c	c	NN	NN	-	14	OBJ	-	-
20	,	,	,	,	-	22	P	-	-
21	adhesion	adhesion	NN	NN	-	22	SUB	-	-
22	was	was	VBD	VBD	-	0	ROOT	-	-
23	assayed	assayed	JJ	JJ	-	22	PRD	-	-
24	as	as	IN	IN	-	23	AMOD	-	-
25	described	described	VBN	VBN	-	24	SBAR	-	-
26	.	.	.	.	-	22	P	-	-

1	immunoprecipitates	immunoprecipitates	NNS	NNS	-	2	SUB	-	-
2	were	were	VBD	VBD	-	0	ROOT	-	-
3	treated	treated	VBN	VBN	-	2	VC	-	-
4	with	with	IN	IN	-	3	VMOD	-	-
5	<num>	<num>	CD	CD	-	6	AMOD	-	-
6	%	%	NN	NN	-	7	NMOD	-	-
7	deoxycholate	deoxycholate	NN	NN	-	11	NMOD	-	-
8	and	and	CC	CC	-	11	NMOD	-	-
9	the	the	DT	DT	-	11	NMOD	-	-
10	released	released	VBN	VBN	-	11	NMOD	-	-
11	material	material	NN	NN	-	4	PMOD	-	-
12	assayed	assayed	VBN	VBN	-	11	NMOD	-	-
13	for	for	IN	IN	-	12	VMOD	-	-
14	drtf1/e2f	drtf1/e2f	JJ	JJ	-	15	NMOD	-	-
15	activity	activity	NN	NN	-	13	PMOD	-	-
16	in	in	IN	IN	-	15	NMOD	-	-
17	gel	gel	NN	NN	-	18	NMOD	-	-
18	retardation	retardation	NN	NN	-	16	PMOD	-	-
19	.	.	.	.	-	2	P	-	-

1	binding	binding	NN	NN	-	2	SUB	-	-
2	was	was	VBD	VBD	-	0	ROOT	-	-
3	assayed	assayed	JJ	JJ	-	2	PRD	-	-
4	using	using	VBG	VBG	-	2	VMOD	-	-
5	intact	intact	JJ	JJ	-	6	NMOD	-	-
6	cos	cos	NNS	NNS	-	4	OBJ	-	-
7	cells	cells	NNS	NNS	-	8	SUB	-	-
8	expressing	expressing	VBG	VBG	-	6	NMOD	-	-
9	the	the	DT	DT	-	12	NMOD	-	-
10	cloned	cloned	JJ	JJ	-	12	NMOD	-	-
11	human	human	JJ	JJ	-	12	NMOD	-	-
12	nk-1r	nk-1r	NN	NN	-	15	NMOD	-	-
13	or	or	CC	CC	-	15	NMOD	-	-
14	its	its	PRP$	PRP$	-	15	NMOD	-	-
15	mutants	mutants	NNS	NNS	-	8	OBJ	-	-
16	.	.	.	.	-	2	P	-	-

1	pancreatic	pancreatic	JJ	JJ	-	2	NMOD	-	-
2	contents	contents	NNS	NNS	-	7	SUB	-	-
3	of	of	IN	IN	-	2	NMOD	-	-
4	dna	dna	NNS	NNS	-	6	NMOD	-	-
5	and	and	CC	CC	-	6	NMOD	-	-
6	rna	rna	NNS	NNS	-	3	PMOD	-	-
7	were	were	VBD	VBD	-	0	ROOT	-	-
8	assayed	assayed	VBN	VBN	-	7	VC	-	-
9	by	by	IN	IN	-	8	VMOD	-	-
10	the	the	DT	DT	-	12	NMOD	-	-
11	fluorimetric	fluorimetric	JJ	JJ	-	12	NMOD	-	-
12	method	method	NN	NN	-	9	PMOD	-	-
13	of	of	IN	IN	-	12	NMOD	-	-
14	boer	boer	NN	NN	-	13	PMOD	-	-
15	but	but	CC	CC	-	8	VMOD	-	-
16	using	using	VBG	VBG	-	8	VMOD	-	-
17	an	an	DT	DT	-	19	NMOD	-	-
18	excitation	excitation	NN	NN	-	19	NMOD	-	-
19	wavelength	wavelength	NN	NN	-	16	OBJ	-	-
20	of	of	IN	IN	-	19	NMOD	-	-
21	<num>	<num>	CD	CD	-	26	NMOD	-	-
22	nm	nm	NN	NN	-	26	NMOD	-	-
23	and	and	CC	CC	-	26	NMOD	-	-
24	an	an	DT	DT	-	26	NMOD	-	-
25	emission	emission	NN	NN	-	26	NMOD	-	-
26	wavelength	wavelength	NN	NN	-	20	PMOD	-	-
27	of	of	IN	IN	-	26	NMOD	-	-
28	<num>	<num>	CD	CD	-	29	NMOD	-	-
29	nm	nm	NN	NN	-	27	PMOD	-	-
30	.	.	.	.	-	7	P	-	-

1	extracts	extracts	NNS	NNS	-	3	NMOD	-	-
2	and	and	CC	CC	-	3	NMOD	-	-
3	supernatants	supernatants	NNS	NNS	-	4	SUB	-	-
4	were	were	VBD	VBD	-	0	ROOT	-	-
5	assayed	assayed	JJ	JJ	-	4	PRD	-	-
6	for	for	IN	IN	-	4	VMOD	-	-
7	bile	bile	JJ	JJ	-	8	NMOD	-	-
8	acids	acids	NNS	NNS	-	6	PMOD	-	-
9	using	using	VBG	VBG	-	8	NMOD	-	-
10	a	a	DT	DT	-	13	NMOD	-	-
11	fluorimetric	fluorimetric	JJ	JJ	-	13	NMOD	-	-
12	enzymatic	enzymatic	JJ	JJ	-	13	NMOD	-	-
13	assay	assay	NN	NN	-	9	OBJ	-	-
14	(	(	-LRB-	-LRB-	-	16	P	-	-
15	sterognost	sterognost	JJ	JJ	-	16	NMOD	-	-
16	3α-flu	3α-flu	NNP	NNP	-	9	PMOD	-	-
17	,	,	,	,	-	4	P	-	-
18	nycomed	nycomed	VBD	VBD	-	4	VMOD	-	-
19	as	as	RB	RB	-	18	VMOD	-	-
20	,	,	,	,	-	18	P	-	-
21	oslo	oslo	NNP	NNP	-	23	NMOD	-	-
22	,	,	,	,	-	21	P	-	-
23	norway	norway	NN	NN	-	18	OBJ	-	-
24	)	)	-RRB-	-RRB-	-	18	P	-	-
25	.	.	.	.	-	4	P	-	-

1	after	after	IN	IN	-	8	VMOD	-	-
2	two	two	CD	CD	-	3	NMOD	-	-
3	washes	washes	NNS	NNS	-	1	PMOD	-	-
4	,	,	,	,	-	8	P	-	-
5	the	the	DT	DT	-	7	NMOD	-	-
6	stained	stained	JJ	JJ	-	7	NMOD	-	-
7	cells	cells	NNS	NNS	-	8	SUB	-	-
8	were	were	VBD	VBD	-	0	ROOT	-	-
9	assayed	assayed	JJ	JJ	-	8	PRD	-	-
10	for	for	IN	IN	-	9	AMOD	-	-
11	fluorescence	fluorescence	NN	NN	-	12	NMOD	-	-
12	intensity	intensity	NN	NN	-	10	PMOD	-	-
13	on	on	IN	IN	-	8	VMOD	-	-
14	a	a	DT	DT	-	17	NMOD	-	-
15	facscan	facscan	JJ	JJ	-	17	NMOD	-	-
16	cell	cell	NN	NN	-	17	NMOD	-	-
17	sorter	sorter	NN	NN	-	13	PMOD	-	-
18	(	(	-LRB-	-LRB-	-	20	P	-	-
19	becton	becton	JJ	JJ	-	20	NMOD	-	-
20	dickinson	dickinson	NN	NN	-	17	NMOD	-	-
21	,	,	,	,	-	25	P	-	-
22	mountain	mountain	NN	NN	-	23	NMOD	-	-
23	view	view	NN	NN	-	25	SUB	-	-
24	,	,	,	,	-	25	P	-	-
25	ca	ca	MD	MD	-	20	NMOD	-	-
26	,	,	,	,	-	25	P	-	-
27	usa	usa	''	''	-	25	P	-	-
28	)	)	-RRB-	-RRB-	-	25	P	-	-
29	.	.	.	.	-	8	P	-	-

